F. Svec et Jr. Porter, THE ACTIONS OF EXOGENOUS DEHYDROEPIANDROSTERONE IN EXPERIMENTAL-ANIMALS AND HUMANS, Proceedings of the Society for Experimental Biology and Medicine, 218(3), 1998, pp. 174-191
Dehydroepiandrosterone (DHEA) is the major adrenal steroid of young ad
ults; however, its physiologic functions, if any, are not known. The p
urpose of this review is to evaluate the current literature in which D
HEA was administered to either humans or experimental animals to disce
rn what these functions might be. Reports are divided into five areas:
neurologic, immunologic, cardiovascular, oncologic, and metabolic. Pa
rticular attention is paid to the dosage and route of administration.
This type of analysis shows that at the lowest doses, DHEA has effects
on neurologic and immunologic tissues, suggesting that these two site
s may be physiologic targets. DHEA also affects cardiologic and metabo
lic functions as well as tumor growth, but such actions require higher
doses and may reflect 'pharmacologic' activities. It is proposed that
DHEA's pattern of activity represents a new class of steroid hormones
, the ''Regnantoids.'' Further progress in the endocrinology of this f
amily of steroids may only come when synthetic, long-acting analogs of
DHEA are available for in vitro studies to allow correlations between
hormone action and receptor binding.